文献速递关节外科

55岁以下患者全髋关节置换术的中期生存率

Mid-Term Survival of Total Hip Arthroplasty in Patients Younger Than 55-year-old.
PubMed 文献 · J Arthroplasty · 2022-02-28

回顾性分析2007年9月至2014年8月在同一机构使用同一厂商组件行初次全髋关节置换术的2461例患者(2814髋),其中55岁及以下643髋、55岁以上2171髋,均使用维生素E稳定高交联聚乙烯内衬;平均随访5.0年,12年全因翻修生存率年轻组97.5%与年长组97.1%相似(P=.8808),作者认为现代聚乙烯可能改善年轻患者生存率。

要点

  • 55岁及以下患者12年全因翻修生存率为97.5%(95%CI:±0.7%),55岁以上为97.1%(95%CI:±0.6%),两组相似(P=.8808)。
  • 总体最常见翻修原因为假体周围股骨骨折(21例;0.75%)。
  • 单因素分析显示假体周围股骨骨折风险因素为女性(P=.28)和年龄≥65岁(P=.012)。

核心结论

  • 全髋关节置换术中使用现代聚乙烯(如维生素E稳定高交联聚乙烯)内衬可能改善年轻患者的生存率。
  • 使用高交联聚乙烯内衬行初次全髋关节置换术的年轻患者在中期末随访时翻修率未增加。

研究设计与样本

  • 回顾性综述纳入2007年9月至2014年8月在本机构行初次全髋关节置换术、随访至少2年的2461例同意患者(2814髋),均使用同一厂商(Zimmer Biomet)组件,全部为维生素E浸润高交联聚乙烯髋臼内衬。
  • 55岁及以下患者561例(643髋;23%),55岁以上患者1900例(2171髋;77%)。

主要发现

  • 两组平均随访均为5.0年。
  • 年轻组男性比例(55%)高于年长组(41%)。
  • 年轻患者体重指数较高,且不依赖性别。
  • 两组Harris髋关节评分(HHS)改善相似。
  • 12年全因翻修Kaplan-Meier生存率两组相似(P=.8808),年轻组为97.5%(95%CI:±0.7%),年长组为97.1%(95%CI:±0.6%)。

关键数值与推荐

  • 总体最常见翻修原因为假体周围股骨骨折(21例;0.75%)。
  • 单因素分析显示假体周围股骨骨折风险因素为女性(P=.28)和年龄≥65岁(P=.012)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Survivorship of total hip arthroplasty (THA) in younger patients is concerning given the inverse relationship between age and lifetime risk for revision. The purpose of this study is to determine if risk of revision has improved for patients aged 55 years or younger who undergo primary THA using modern polyethylene liners. METHODS: A retrospective review identified 2,461 consented patients (2,814 hips) with minimum 2-year follow-up who underwent primary THA at our institution between September 2007 and August 2014 using components from a single manufacturer (Zimmer Biomet), all with vitamin E-infused highly crosslinked polyethylene acetabular inserts. There were 561 patients (643 THA; 23%) aged 55 or younger and 1,900 (2,171 THA; 77%) older than 55. RESULTS: Mean follow-up was 5.0 years for both groups. There were more male patients in the younger (55%) than older (41%) group. Body mass index (BMI) was higher in younger patients independent of gender. Improvement in Harris hip score (HHS) was similar between groups. Kaplan-Meier survival to endpoint of all cause revision was similar between groups at 12 years (P = .8808) with 97.5% (95% CI: ±0.7%) for younger versus 97.1% (95% CI: ±0.6%) for older patients. Most frequent reason for revision overall was periprosthetic femoral fracture (21; 0.75%); univariate analysis revealed risk factors were female gender (P = .28) and age ≥65 years (P = .012). CONCLUSION: Use of modern polyethylene, such as vitamin E-stabilized highly cross-linked, liners during THA may improve survivorship in younger patients undergoing THA. Younger patients undergoing primary THA with highly cross-linked polyethylene liners had no increased rate of revision at mid-term follow-up.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lombardi AV, Byrd ZO, Berend KR, et al. Mid-Term Survival of Total Hip Arthroplasty in Patients Younger Than 55-year-old. J Arthroplasty. 2022. PMID: 35240281. doi:10.1016/j.arth.2022.02.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。